The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,597,277 in first-year total cost, median $460,707.
Most frequent study sections
- Special Emphasis Panel[ZHD1 DSR-T (50)]8
Most frequent institutions
- CHILDREN'S HOSP OF PHILADELPHIA1
- CINCINNATI CHILDRENS HOSP MED CTR1
- INDIANA UNIVERSITY INDIANAPOLIS1
- THOMAS JEFFERSON UNIVERSITY1
- UNIV OF ARKANSAS FOR MED SCIS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Neonatal Treatment Trial1UG1HD107631-01 | DEMAURO, SARA BONAMOLORCH, SCOTT A | CHILDREN'S HOSP OF PHILADELPHIA, PA | $528,000 | ZHD1 |
| 2021 | HEAL initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial: Cincinnati site1UG1HD107616-01 | MERHAR, STEPHANIE L | CINCINNATI CHILDRENS HOSP MED CTR, OH | $474,473 | ZHD1 |
| 2021 | Incorporating nonpharmacologic approaches into a comparative effectiveness pharmacologic trial for neonates with neonatal opioid withdrawal syndrome (NOWS)1UG1HD107653-01 | SOKOL, GREGORY M. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $468,862 | ZHD1 |
| 2021 | Neonatal Opioid Withdrawal Syndrome (NOWS) in Kentucky: Improving Outcomes for Infants1UG1HD107649-01 | DEVLIN-PHINNEY, LORI ANNTELANG, SUCHETA | UNIVERSITY OF LOUISVILLE, KY | $465,484 | ZHD1 |
| 2021 | HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial Clinical Site1UG1HD107650-01 | HALL, RICHARD WHITTINGTON | UNIV OF ARKANSAS FOR MED SCIS, AR | $455,930 | ZHD1 |
| 2021 | HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial New Mexico Site1UG1HD107627-01 | LEEMAN, LAWRENCE M | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $445,388 | ZHD1 |
| 2021 | UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments1UG1HD107580-01 | AMBALAVANAN, NAMASIVAYAM | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $442,908 | ZHD1 |
| 2021 | Thomas Jefferson University Hospital Clinical Site for HEAL NOWS Pharmacologic Trial1UG1HD107628-01 | ADENIYI-JONES, SUSANKRAFT, WALTER K | THOMAS JEFFERSON UNIVERSITY, PA | $316,232 | ZHD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.